Vizgen’s Post

Shares in LungLife AI Inc (AIM:LLAI), a developer of diagnostic solutions for early #LungCancer detection, jumped 43% following the successful validation of its #LungLB test. This diagnostic, crucial in identifying cancerous lung nodules, especially in smaller nodules (smaller than 15 mm), demonstrated an 81% positive predictive value (PPV), significantly outperforming the current standard of around 60% PPV. This advancement is pivotal in early cancer detection, addressing the challenge of diagnosing "intermediate" risk nodules which constitute about 87% of small nodules. LungLB also surpassed the Mayo Risk Model and PET scans in effectiveness, with a 72% area under the curve (AUC) compared to Mayo's 62% and a 21% higher PPV than PET in small nodules, offering a more robust diagnostic tool for physicians. At 8.31 am, the stock was changing hands for 65.92p, up 19.92p. More at #Proactive #ProactiveInvestors #AIM #LLAI #LungLife #LungLifeAI #LungLifeAIInc http://ow.ly/6zvR1057zyI

Unraveling the intricate interplay of cells within tumors requires innovative tools. Multiplex Immunofluorescence (mIF) offers a powerful solution, enabling researchers to visualize immune cell dynamics, comprehend tumor heterogeneity, and accelerate groundbreaking discoveries. By transcending the limitations of traditional methods, mIF unveils hidden patterns that influence treatment response. Ready to revolutionize immuno-oncology? Let's collaborate! www.icuradx.com [email protected] #immunooncology #tumormicroenvironment #mIF #precisionmedicine #spatialbiology

Precision meets innovation in tumor assessment!🧑⚕️Join Gerry Thompson in a groundbreaking on-demand webinar and explore the collaborative #digitalRANO tool's capabilities and transform your approach to tumor assessment. 🔬 https://bit.ly/3OnW6zR

Two-dimensional (2D) cell cultures are widely used, but they lack key features critical for replicating physiological systems. With KIYA-Predict™, 3-dimensional (3D) tissue models allow for complex and dynamic cell-cell communications and cell-matrix interactions that occur during cancer metastasis. See how it works: bit.ly/3Dspheroids #KIYAPredict #Kiyatec #CancerResearch #PrecisionMedicine #FunctionalPrecisionMedicine #DrugDevelopment

Summary: This article discusses the prognostic significance of PET/CT scans and their correlation with immuno-genomic profiling in patients with oesophageal squamous cell carcinoma undergoing immunotherapy and chemoradiotherapy in a phase II study. Hashtags: #CancerImaging #OesophagealCancer #Immunotherapy #Bioimaging #MedicalResearch Read more here: https://lnkd.in/e7qxk3dJ BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

Take your RNA-seq experiments to the next level with insights from Roche! Compare library preparation kits and optimize your tumor profiling workflow for maximum impact. Learn more >>> https://hubs.ly/Q02v0kxG0

ESMO 2024 Quick Takes with LARVOL : Guru Sonpavde, MD Wrapping up our ESMO 2024 coverage, Dr. Sonpavde provides key insights from the AMBASSADOR trial. This randomized phase 3 study explored adjuvant pembrolizumab in high-risk muscle-invasive urothelial carcinoma, demonstrating a nearly doubled median disease-free survival (DFS) — from 14 months to 29 months. With these promising results, could pembrolizumab follow nivolumab’s path to approval in this setting? Stay tuned for more post-ESMO insights and what these findings could mean for future treatments! #ESMO24 #CancerResearch #AMBASSADORTrial #LARVOLQuickTake

"I anticipate that the landscape might change, and there might be a market advantage to more aseptically-produced Actinium-225 to meet the demand in the next few years." - Yasmine Saboui Yasmine Saboui, Director of Process Engineering at Orchestra Life Sciences, discusses important considerations for Actinium-225 production in targeted #cancer therapy. Watch this short clip to learn more about challenges related to the production pathways of Thorium-229 and Thorium-232 as well as alternative approaches to foster advancements in Actinium-225 production for a brighter future in medical treatment. Click here to request a meeting with our experts: https://lnkd.in/gBq_frhv #nuclearmedicine #processengineering

Spatially-defined compartment signatures utilize tumor and tumor microenvironment-specific information, leading to more accurate prediction of treatment outcome in #melanoma

💡Insights from Hesham Gayar, MD: The Potential Clinical Benefits of Upright Positioning In the second instalment of our interview with Dr Gayar from McLaren Flint Proton Therapy Center discover the potential clinical benefits of the upright position. Hear how simplicity, in remaining in a more natural upright position, is poised to offer numerous advantages. Comment below if you have any questions, we will be sharing more progress on our upright solutions arriving at the McLaren Proton Therapy Center very soon! #UprightPositioning #ClinicalBenefits #HealthcareInnovation Please Note: The Leo Cancer Care technology is not clinically available and will not treat patients until the required regulatory clearance has been achieved.